title: Atrial fibrillation, pharmacological cardioversion and topical ophthalmic beta-blocker use.
authors.forename: Salvatore
authors.initials: S
authors.lastname: Patane'
authors.forename: Filippo
authors.initials: F
authors.lastname: Marte
authors.forename: Gianluca
authors.initials: G
authors.lastname: Di Bella
authors.forename: Pietro
authors.initials: P
authors.lastname: Pugliatti
mesh_terms: D000287:Administration, Topical; D000319:Adrenergic beta-Antagonists / Q000009:adverse effects / Q000627:therapeutic use; D000889:Anti-Arrhythmia Agents / Q000008:administration & dosage / Q000009:adverse effects; D001281:Atrial Fibrillation / Q000150:complications / Q000175:diagnosis / Q000188:drug therapy*; D016887:Cardiopulmonary Resuscitation; D004347:Drug Interactions; D015150:Echocardiography, Doppler; D004554:Electric Countershock; D004562:Electrocardiography; D005260:Female; D005500:Follow-Up Studies; D005901:Glaucoma / Q000175:diagnosis / Q000188:drug therapy; D006323:Heart Arrest / Q000139:chemically induced* / Q000628:therapy; D006801:Humans; D008875:Middle Aged; D009883:Ophthalmic Solutions; D011405:Propafenone / Q000008:administration & dosage* / Q000009:adverse effects; D018570:Risk Assessment; D012720:Severity of Illness Index; D013999:Timolol / Q000009:adverse effects* / Q000627:therapeutic use; D016896:Treatment Outcome
chemical_list: D000319:Adrenergic beta-Antagonists; D000889:Anti-Arrhythmia Agents; D009883:Ophthalmic Solutions; D011405:Propafenone; D013999:Timolol